NEWARK, Calif.--April 2, 2018 via Business Wire
Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology company developing neuromodulators for use in treating aesthetic and underserved therapeutic conditions, today announced the appointments of Dustin Sjuts as Vice President of Strategy and Sales, Aesthetic and Therapeutic; Ben Putman as Vice President of Digital; and Marc Korenberg as Senior Director of Commercial Operations. In addition,…
ContinuePosted on April 11, 2018 at 1:20pm
© 2024 Created by dermRounds Dermatology Network. Powered by
Comment Wall
You need to be a member of dermRounds Dermatology Network to add comments!
Join dermRounds Dermatology Network